HighVista Strategies »

Autolus Therapeutics Plc spon ads shares owned by HighVista Strategies

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 261k 6.38

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Merus N V (MRUS)
Microsoft Corporation (MSFT)
Arcellx Common Stock (ACLX)
Xpo Logistics Inc equity (XPO)
Nuvalent Inc-a (NUVL)
Ansys (ANSS)
Hess (HES)
Ideaya Biosciences (IDYA)
Juniper Networks (JNPR)
Sp Plus (SP)
Cerevel Therapeutics Hldng I (CERE)
Albertsons Cos Common Stock (ACI)

View all positions for HighVista Strategies

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
FMR
Polygon Management
Cormorant Asset Management
Paradigm Biocapital Advisors
T. Rowe Price Associates
Armistice Capital
Frazier Life Sciences Management
Perceptive Advisors
BlackRock
Deerfield Management Company
Adage Capital Partners GP
Commodore Capital
Perpetual

View all funds holding Autolus Therapeutics Plc spon ads